Boulanger MC - Search Results

1

Molecular biology of calcific aortic valve disease: towards new pharmacological therapies.

Mathieu P, Boulanger MC, Bouchareb R. Mathieu P, et al. Among authors: boulanger mc. Expert Rev Cardiovasc Ther. 2014 Jul;12(7):851-62. doi: 10.1586/14779072.2014.923756. Epub 2014 May 24. Expert Rev Cardiovasc Ther. 2014. PMID: 24857537 Review.

2

Altered DNA Methylation of Long Noncoding RNA H19 in Calcific Aortic Valve Disease Promotes Mineralization by Silencing NOTCH1.

Hadji F, Boulanger MC, Guay SP, Gaudreault N, Amellah S, Mkannez G, Bouchareb R, Marchand JT, Nsaibia MJ, Guauque-Olarte S, Pibarot P, Bouchard L, Bossé Y, Mathieu P. Hadji F, et al. Among authors: boulanger mc. Circulation. 2016 Dec 6;134(23):1848-1862. doi: 10.1161/CIRCULATIONAHA.116.023116. Epub 2016 Oct 27. Circulation. 2016. PMID: 27789555

3

Activated platelets promote an osteogenic programme and the progression of calcific aortic valve stenosis.

Bouchareb R, Boulanger MC, Tastet L, Mkannez G, Nsaibia MJ, Hadji F, Dahou A, Messadeq Y, Arsenault BJ, Pibarot P, Bossé Y, Marette A, Mathieu P. Bouchareb R, et al. Among authors: boulanger mc. Eur Heart J. 2019 May 1;40(17):1362-1373. doi: 10.1093/eurheartj/ehy696. Eur Heart J. 2019. PMID: 30395215 Free PMC article.

4

Soluble CD14 is associated with the structural failure of bioprostheses.

Nsaibia MJ, Boulanger MC, Bouchareb R, Mkannez G, Dahou A, Salaun E, Bossé Y, Clavel MA, Arsenault BJ, Pibarot P, Mathieu P. Nsaibia MJ, et al. Among authors: boulanger mc. Clin Chim Acta. 2018 Oct;485:173-177. doi: 10.1016/j.cca.2018.06.045. Epub 2018 Jun 30. Clin Chim Acta. 2018. PMID: 29966619

5

Ectopic visceral fat: a clinical and molecular perspective on the cardiometabolic risk.

Mathieu P, Boulanger MC, Després JP. Mathieu P, et al. Among authors: boulanger mc. Rev Endocr Metab Disord. 2014 Dec;15(4):289-98. doi: 10.1007/s11154-014-9299-3. Rev Endocr Metab Disord. 2014. PMID: 25326657 Review.

6

Adenosine derived from ecto-nucleotidases in calcific aortic valve disease promotes mineralization through A2a adenosine receptor.

Mahmut A, Boulanger MC, Bouchareb R, Hadji F, Mathieu P. Mahmut A, et al. Among authors: boulanger mc. Cardiovasc Res. 2015 Apr 1;106(1):109-20. doi: 10.1093/cvr/cvv027. Epub 2015 Feb 2. Cardiovasc Res. 2015. PMID: 25644539

7

Autotaxin and Lipoprotein Metabolism in Calcific Aortic Valve Disease.

Mathieu P, Boulanger MC. Mathieu P, et al. Among authors: boulanger mc. Front Cardiovasc Med. 2019 Mar 1;6:18. doi: 10.3389/fcvm.2019.00018. eCollection 2019. Front Cardiovasc Med. 2019. PMID: 30881959 Free PMC article. Review.

8

DNA methylation of a PLPP3 MIR transposon-based enhancer promotes an osteogenic programme in calcific aortic valve disease.

Mkannez G, Gagné-Ouellet V, Jalloul Nsaibia M, Boulanger MC, Rosa M, Argaud D, Hadji F, Gaudreault N, Rhéaume G, Bouchard L, Bossé Y, Mathieu P. Mkannez G, et al. Among authors: boulanger mc. Cardiovasc Res. 2018 Sep 1;114(11):1525-1535. doi: 10.1093/cvr/cvy111. Cardiovasc Res. 2018. PMID: 29726894 Free PMC article.

9

A transcriptome-wide association study identifies PALMD as a susceptibility gene for calcific aortic valve stenosis.

Thériault S, Gaudreault N, Lamontagne M, Rosa M, Boulanger MC, Messika-Zeitoun D, Clavel MA, Capoulade R, Dagenais F, Pibarot P, Mathieu P, Bossé Y. Thériault S, et al. Among authors: boulanger mc. Nat Commun. 2018 Mar 7;9(1):988. doi: 10.1038/s41467-018-03260-6. Nat Commun. 2018. PMID: 29511167 Free PMC article.

10

Pathobiology of Lp(a) in calcific aortic valve disease.

Mathieu P, Arsenault BJ, Boulanger MC, Bossé Y, Koschinsky ML. Mathieu P, et al. Among authors: boulanger mc. Expert Rev Cardiovasc Ther. 2017 Oct;15(10):797-807. doi: 10.1080/14779072.2017.1367286. Epub 2017 Aug 24. Expert Rev Cardiovasc Ther. 2017. PMID: 28816078 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results